(Synopsis) 20/11/1998 4. Circular 3/2543 27/09/2000 27/09/2000 5. Circular 37/2545 24/12/2002 6. Circular 20/2541 06/07/1998 7. Circular 15/2538 23/08/1995 8. Circular 15/2537 19/08
(Synopsis) 20/11/1998 4. Circular 3/2543 27/09/2000 27/09/2000 5. Circular 37/2545 24/12/2002 6. Circular 20/2541 06/07/1998 7. Circular 15/2538 23/08/1995 8. Circular 15/2537 19/08
of consideration basis, calculated from the Company’s reviewed consolidated financial statements for 6-month period as of 30 June 2018. Therefore, the entering of transaction when combined with the
consideration basis, calculated from the Company’s reviewed consolidated financial statements for a 9-month period as of 30 September 2018. Therefore, the entering of this transaction when combined with the
consideration basis, calculated from the Company’s reviewed consolidated financial statements for a 9-month period as of 30 September 2018. Therefore, the entering of this transaction when combined with the
PET, Packaging and Specialty Chemicals are now grouped under Combined PET given the inter-related nature of their businesses. Table 2: Segment Results (New Grouping) Full year $million (except where
Printable Format - Laws and Regulations Marketing |- Approval and Standards Practice |- Code of Conduct |- Fees |- Related Circular Letter Bond Dealer and Underwriter |- Fees (section 14 and 19
Report on Assets of Customers (Synopsis) 16. Circular 24/2547 14/05/2004 17. Circular 7/2544 22/01/2001 18. Circular 16/2543 12/07/2000 19. Circular 2/2543 08/02/2000 20
Report on Assets of Customers (Synopsis) 16. Circular 24/2547 14/05/2004 17. Circular 7/2544 22/01/2001 18. Circular 16/2543 12/07/2000 19. Circular 2/2543 08/02/2000 20
Report on Assets of Customers (Synopsis) 16. Circular 24/2547 14/05/2004 17. Circular 7/2544 22/01/2001 18. Circular 16/2543 12/07/2000 19. Circular 2/2543 08/02/2000 20